NEW YORK, Aug. 10, 2016 /PRNewswire/ -- Attorney
Advertising -- Bronstein, Gewirtz & Grossman, LLC is
investigating potential claims on behalf of purchasers of the
securities American Renal Associates Holdings, Inc. ("American
Renal Associates" or the "Company") (NYSE: ARA). Such investors are
advised to contact Peretz Bronstein
or his investor relations analyst, Yael
Hurwitz at info@bgandg.com or 212-697-6484.
The investigation concerns whether American Renal Associates and
certain of its officers and/or directors have breached its
fiduciary duties to shareholders and engaged in Health Insurance
Fraud.
According to the complaint, American Renal Associates engaged in
a "fraudulent and illegal scheme" to obtain higher reimbursement
payments by convincing patients to sign up for health insurance
plans with UnitedHealthcare of Florida, Inc. UnitedHealthcare of Ohio, Inc. and All Savers Insurance Company
(collectively, "United") for dialysis services given for patients
suffering from end-stage renal disease. American Renal Associates
purposely targeted Medicaid- and Medicare-eligible patients to
persuade them to switch from their affordable government insurance
plan to join United's plans in order to boost its own profits when
billing. Medicare and Medicaid pay American Renal Associates
roughly $300 per dialysis session,
while American Renal Associates does not have a contracted rate for
United's plans, and has allegedly billed United up to twenty times
the Medicaid and Medicare rate. United has thus overpaid millions
of dollars to American Renal Associates as part of its unprincipled
billing scheme.
If you purchased American Renal Associates shares or if you are
aware of any facts relating to this investigation, you can assist
this investigation by visiting the firm's site:
http://www.bgandg.com/ara. You can also contact Peretz Bronstein or his Investor Relations
Analyst, Yael Hurwitz of Bronstein,
Gewirtz & Grossman, LLC: 212-697-6484 or via email
info@bgandg.com. Those who inquire by e-mail are encouraged
to include their mailing address, email and telephone number.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation
boutique. Our primary expertise is the aggressive pursuit of
litigation claims on behalf of our clients. In addition to
representing institutions and other investor plaintiffs in class
action security litigation, the firm's expertise includes general
corporate and commercial litigation, as well as securities
arbitration. Attorney advertising. Prior results do not
guarantee similar outcomes.
Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/shareholder-alert-bronstein-gewirtz--grossman-llc-announces-investigation-of-american-renal-associates-holdings-inc-ara-300311315.html
SOURCE Bronstein, Gewirtz & Grossman, LLC